www.fdanews.com/articles/86327-seattle-genetics-and-laureate-pharma-announce-manufacturing-agreement
SEATTLE GENETICS AND LAUREATE PHARMA ANNOUNCE MANUFACTURING AGREEMENT
April 25, 2006
Seattle Genetics, Inc. and Laureate Pharma, Inc. announced today that they have entered into an agreement for manufacturing of Seattle Genetics' SGN-33 and SGN-70 humanized monoclonal antibody product candidates. Under the terms of the agreement, Laureate Pharma will perform scale-up and cGMP manufacturing of clinical trial materials for both programs.
Business Wire